CLINICAL TRIALS PROFILE FOR SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
✉ Email this page to a colleague
All Clinical Trials for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01928082 ↗ | The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass | Terminated | University of Chicago | Phase 2 | 2013-08-01 | The purpose of this study is to assess if estrogen replacement normalizes urinary calcium excretion in postmenopausal women with hypercalciuria and low bone mass and to assess for differences in response to estrogen replacement in women with familial hypercalciuria compared to nonfamilial hypercalciuria. |
| NCT02124447 ↗ | Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy | Withdrawn | Medical College of Wisconsin | N/A | 2014-06-01 | This will be a 4-way comparison to prospectively evaluate the efficacy and patient tolerability of four commercially available bowel preparations among patients undergoing colonoscopy for screening and surveillance in a single tertiary academic medical center. |
| NCT02523911 ↗ | Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening | Withdrawn | Mercy Medical Center, Des Moines, Iowa | N/A | 2016-03-01 | The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening. |
| NCT02523911 ↗ | Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening | Withdrawn | MercyOne Des Moines Medical Center | N/A | 2016-03-01 | The purpose of this study is to investigate Suprep bowel preparation, with and without the anti-gas medication simethicone, in terms of efficacy and patient tolerability in the preparation of patients undergoing routine colonoscopy for colorectal cancer screening. |
| NCT03299452 ↗ | Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Unknown status | Alphacait, LLC | Phase 2 | 2017-01-01 | This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor. |
| NCT03299452 ↗ | Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Unknown status | Haining Health-Coming Biotech Co., Ltd. | Phase 2 | 2017-01-01 | This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor. |
| NCT04225793 ↗ | The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy | Recruiting | Russian Society of Colorectal Surgeons | N/A | 2019-06-02 | The gold standard of colorectal examination is colonoscopy. One of the main purposes of colonoscopy is detecting bowel neoplasms. Right now there are several methods the bowel preparation for the colonoscopy. Several factors can affect the quality of the bowel preparation, such as the kind of oral laxative, the time after its intake and the diet followed in the days before colonoscopy. In this randomized clinical trial the investigators aimed to compare the safety and efficiency of two low-volume laxatives for bowel preparation: potassium, magnesium and sodium sulphates-based laxative Eziclen (IPSEN, France) and Macrogol-3350 + Sodium Sulfate + Potassium Chloride+ Sodium Chloride + Ascorbic Acid-based and Sodium Ascorbate-based Moviprep (Nordgine B.V., The Netherlands) |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Condition Name
Clinical Trial Locations for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Trials by Country
Clinical Trial Progress for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Clinical Trial Phase
Clinical Trial Sponsors for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Sponsor Name
